Cargando…
Preference criteria for regorafenib in treating refractory metastatic colorectal cancer are the small tumor burden, slow growth and poor/scanty spread
Given the unclear preference criteria for regorafenib in treating refractory metastatic colorectal cancer (mCRC), this study aimed to construct an algorithm in selecting right patients for regorafenib. This was a multicenter retrospective cohort study. Patients with pathology confirmed mCRC and admi...
Autores principales: | Hsu, Hung-Chih, Huang, Kuo-Cheng, Chen, Wei-Shone, Jiang, Jeng-Kai, Yang, Shung-Haur, Wang, Huann-Sheng, Chang, Shih-Ching, Lan, Yuan-Tzu, Lin, Chun-Chi, Lin, Hung-Hsin, Huang, Sheng-Chieh, Cheng, Hou-Hsuan, Yang, Tsai-Sheng, Chen, Chien-Chih, Chao, Yee, Teng, Hao-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319410/ https://www.ncbi.nlm.nih.gov/pubmed/34321583 http://dx.doi.org/10.1038/s41598-021-94968-x |
Ejemplares similares
-
A Long-Term and Large-Scale Real-World Study in Taiwan: Efficacy of Target Therapy in Stage IV Colorectal Cancer
por: Huang, Sheng-Chieh, et al.
Publicado: (2022) -
Three-dimensional versus conventional two-dimensional laparoscopic colectomy for colon cancer: A 3-year follow-up study
por: Yang, Yi-Wen, et al.
Publicado: (2022) -
The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon
por: Lee, Kun-Han, et al.
Publicado: (2021) -
Risk factors for delayed perineal wound healing and its impact on prolonged hospital stay after abdominoperineal resection
por: Chang, Chu-Cheng, et al.
Publicado: (2019) -
Differences in gene mutations according to gender among patients with colorectal cancer
por: Tsai, Yi-Jian, et al.
Publicado: (2018)